Link between immune response and parasite synchronization in malaria.
Anti-malaria vaccines and drugs could be greatly improved if we knew which phases of Plasmodium falciparum development in red blood cells are major inducers and which are major targets of natural immune responses. This information should focus attention on relevant immunogens and prove useful in developing immune-based therapies. Here we explore the hypothesis that innate immune responses mediate synchronization between the replication cycles of parasites in different red blood cells which is reflected in periodic fevers. Based on a recently developed, rather general mathematical model, we find that periodicity is highly sensitive to the position of both the inducing phase interval and the target phase interval in the parasite replication cycle. In addition, the degree of variability in the length of the replication cycle also strongly affects periodicity. To produce synchronization, the inducing and the target phase intervals must be developmentally distant from each other. We developed a computer program which prompts for information based on measurements of the numbers of erythrocytes in two replication cycle intervals chosen by the researcher, tests our model, and predicts the two phase intervals most critical to the synchronizing immune response. The program can be obtained from the authors.
Rouzine
Igor M
IM
Department of Microbiology and Molecular Biology, Tufts University, 136 Harrison Avenue, Boston, MA 02111, USA. irouzine@tufts.edu
McKenzie
F Ellis
FE
D000818:Animals; D003198:Computer Simulation; D004912:Erythrocytes / Q000469:parasitology; D006790:Host-Parasite Interactions / Q000276:immunology; D006801:Humans; D007700:Kinetics; D016778:Malaria, Falciparum / Q000276:immunology* / Q000469:parasitology* / Q000628:therapy; D008954:Models, Biological; D018512:Parasitemia / Q000276:immunology / Q000469:parasitology / Q000628:therapy; D010507:Periodicity; D010963:Plasmodium falciparum / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity